Feil Family Brain & Mind Research Institute

You are here

Publications

Found 390 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kamel H.  2018.  Additional Factors in Considering Patent Foramen Ovale Closure to Prevent Recurrent Ischemic Stroke-Reply.. JAMA Neurol.
Kamel H.  2019.  Does Left Atrial Mechanical Dysfunction Contribute to a Thrombogenic Atrial Myopathy? JACC Cardiovasc Imaging.
Kamel H, Chung CD, Kone GJ, Gupta A, Morris NA, Fink ME, Navi BB.  2018.  Medical Specialties of Clinicians Providing Mechanical Thrombectomy to Patients With Acute Ischemic Stroke in the United States.. JAMA Neurol.
Kamel H, Merkler AE, Iadecola C, Gupta A, Navi BB.  2019.  Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review.. JAMA Neurol.
Kamel H, Roman MJ, Pitcher A, Devereux RB.  2016.  Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis.. Circulation. 134(7):527-33.
Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MSV.  2014.  Risk of a thrombotic event after the 6-week postpartum period.. N Engl J Med. 370(14):1307-15.
Kamel H, Healey JS.  2017.  Cardioembolic Stroke.. Circ Res. 120(3):514-526.
Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA et al..  2018.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.. Int J Stroke. :1747493018799981.
Kamel H.  2017.  Evidence-Based Management of Patent Foramen Ovale in Patients With Ischemic Stroke.. JAMA Neurol.
Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR et al..  2018.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).. Stroke.
Kamel H.  2017.  Response by Kamel to Letter Regarding Article, "Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis".. Circulation. 135(12):e782.
Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, Okin PM, Sacco RL, Soliman EZ, Elkind MSV.  2015.  Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.. Stroke. 46(11):3208-12.
Kamel H, Gialdini G, Baradaran H, Giambrone AE, Navi BB, Lerario MP, Min JK, Iadecola C, Gupta A.  2017.  Cryptogenic Stroke and Nonstenosing Intracranial Calcified Atherosclerosis.. J Stroke Cerebrovasc Dis. 26(4):863-870.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.  2016.  A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Kawamata H, Manfredi G.  2017.  Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases.. J Cell Biol. 216(12):3917-3929.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..  2017.  Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.
Kenny TC, Manfredi G, Germain D.  2017.  The Mitochondrial Unfolded Protein Response as a Non-Oncogene Addiction to Support Adaptation to Stress during Transformation in Cancer and Beyond.. Front Oncol. 7:159.
Khormaee S, Do HT, Mayr Y, Gialdini G, Kamel H, Lyman S, Cross MB.  2018.  Risk of Ischemic Stroke After Perioperative Atrial Fibrillation in Total Knee and Hip Arthroplasty Patients.. J Arthroplasty.
Kim E, Cho S.  2016.  Microglia and Monocyte-Derived Macrophages in Stroke.. Neurotherapeutics. 13(4):702-718.
Kim E, Woo M-S, Qin L, Ma T, Beltran CD, Bao Y, Bailey JA, Corbett D, Ratan RR, Lahiri DK et al..  2015.  Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke.. J Neurosci. 35(45):15113-26.
Kim S-E, Lei Y, Hwang S-H, Wlodarczyk BJ, Mukhopadhyay S, Shaw GM, M Ross E, Finnell RH.  2018.  Dominant negative GPR161 rare variants are risk factors of human spina bifida.. Hum Mol Genet.
Kim E, Yang J, Park KWoo, Cho S.  2017.  Inhibition of VEGF Signaling Reduces Diabetes-Exacerbated Brain Swelling, but Not Infarct Size, in Large Cerebral Infarction in Mice.. Transl Stroke Res.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Koizumi K, Hattori Y, Ahn SJi, Buendia I, Ciacciarelli A, Uekawa K, Wang G, Hiller A, Zhao L, Voss HU et al..  2018.  Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function.. Nat Commun. 9(1):3816.